Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Personalized Medicine|May 26, 2018
Pharmacogenetics and individualized medicine - bridging the gap between pharmacogenetic research and the patientJulia Kirchheiner
Clinical Pharmacology and Therapeutics|January 8, 2005
Clinical consequences of cytochrome P450 2C9 polymorphismsJulia Kirchheiner, Jürgen Brockmöller
Biochimica Et Biophysica Acta|November 23, 2006
Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymesJulia Kirchheiner, Angela Seeringer
Clinics in Laboratory Medicine|December 9, 2008
Pharmacogenetics-guided dose modifications of antidepressantsAngela Seeringer, Julia Kirchheiner
CNS Drugs|March 27, 2009
Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disordersJulia Kirchheiner, Cristina Rodriguez-Antona
Journal of Psychopharmacology (Oxford, England)|June 21, 2006
Contribution of allelic variations in transporters to the phenotype of drug responseJulia Kirchheiner, Dirk Gründemann, Edgar Schömig
Nature Reviews. Drug Discovery|August 2, 2005
Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?Julia Kirchheiner, Uwe Fuhr, Jürgen Brockmöller
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?Julia Kirchheiner, Angela Seeringer, Roberto Viviani
European Journal of Clinical Pharmacology|June 12, 2008
Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rateAngela Seeringer, Jürgen Brockmöller, Steffen Bauer, et al.
Therapeutic Drug Monitoring|December 14, 2006
Therapeutic drug monitoring of mirtazapine, desmethylmirtazapine, 8-hydroxymirtazapine, and mirtazapine-N-oxide by enantioselective HPLC with fluorescence detectionIngolf Meineke, Hannelore Steinmetz, Julia Kirchheiner, et al.
Pageof 7